Literature DB >> 2171511

Receptor-mediated action of hepoxilin A3 releases diacylglycerol and arachidonic acid from human neutrophils.

S Nigam1, S Nodes, G Cichon, E J Corey, C R Pace-Asciak.   

Abstract

We have previously shown that hepoxilin A3 increases the intracellular concentration of Ca+2 in human neutrophils. Herein we address the initial events of hepoxilin action on the neutrophil which precede the rise in intracellular calcium. We show that hepoxilin A3 at 10-1000 nM concentrations releases from [1-14C]-arachidonic acid labeled neutrophils diacylglycerol and unesterified arachidonic acid in a time and concentration dependent fashion. The release of arachidonic acid and diacyglycerol are receptor-mediated events which are blocked by pertussis toxin. This data shows that hepoxilin A3 stimulates phospholipases C and A2 in the cell which may be involved in the rise in cytosolic calcium. Thus, hepoxilins may represent a hitherto unrecognised class of cellular mediators.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171511     DOI: 10.1016/0006-291x(90)90775-i

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Hepoxilins sensitize blood vessels to noradrenaline--stereospecificity of action.

Authors:  O Laneuville; R Couture; C R Pace-Asciak
Journal:  Br J Pharmacol       Date:  1992-02       Impact factor: 8.739

Review 2.  Patatin-like phospholipases in microbial infections with emerging roles in fatty acid metabolism and immune regulation by Apicomplexa.

Authors:  Sarah K Wilson; Laura J Knoll
Journal:  Mol Microbiol       Date:  2017-11-23       Impact factor: 3.501

3.  Mammalian soluble epoxide hydrolase is identical to liver hepoxilin hydrolase.

Authors:  Annette Cronin; Martina Decker; Michael Arand
Journal:  J Lipid Res       Date:  2011-01-07       Impact factor: 5.922

4.  Spinal 12-lipoxygenase-derived hepoxilin A3 contributes to inflammatory hyperalgesia via activation of TRPV1 and TRPA1 receptors.

Authors:  Ann M Gregus; Suzanne Doolen; Darren S Dumlao; Matthew W Buczynski; Toshifumi Takasusuki; Bethany L Fitzsimmons; Xiao-Ying Hua; Bradley K Taylor; Edward A Dennis; Tony L Yaksh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-09       Impact factor: 11.205

5.  Systematic analysis of rat 12/15-lipoxygenase enzymes reveals critical role for spinal eLOX3 hepoxilin synthase activity in inflammatory hyperalgesia.

Authors:  Ann M Gregus; Darren S Dumlao; Spencer C Wei; Paul C Norris; Laura C Catella; Flore G Meyerstein; Matthew W Buczynski; Joanne J Steinauer; Bethany L Fitzsimmons; Tony L Yaksh; Edward A Dennis
Journal:  FASEB J       Date:  2013-02-04       Impact factor: 5.191

6.  Neurokinin A-induced contraction of guinea-pig isolated trachea: potentiation by hepoxilins.

Authors:  O Laneuville; R Couture; C R Pace-Asciak
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

7.  Hepoxilin A3 inhibits the rise in free intracellular calcium evoked by formyl-methionyl-leucyl-phenylalanine, platelet-activating factor and leukotriene B4.

Authors:  O Laneuville; D Reynaud; S Grinstein; S Nigam; C R Pace-Asciak
Journal:  Biochem J       Date:  1993-10-15       Impact factor: 3.857

8.  A lipid mediator hepoxilin A3 is a natural inducer of neutrophil extracellular traps in human neutrophils.

Authors:  David N Douda; Hartmut Grasemann; Cecil Pace-Asciak; Nades Palaniyar
Journal:  Mediators Inflamm       Date:  2015-02-16       Impact factor: 4.711

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.